Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||EW3143 / 1||- / -|
Administered by: Other Purchased by: ??
Symptoms: Chest pain
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Preexisting Conditions: Comments: NA Patient has not had symptoms associated with COVID-19 Not had a COVID-19 test Patient is not enrolled in clinical trial
Diagnostic Lab Data:
CDC 'Split Type': GBPFIZER INC2021657226
Write-up: Chest pain; This is a spontaneous report from a contactable consumer received from the Regulatory Agency. The regulatory authority report number is GB-MHRA-WEBCOVID-202106041226009700-BAUM5. Safety Report Unique Identifier: GB-MHRA-ADR 25419998. A 31-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EW3143), via an unspecified route of administration on 04Jun2021 (at the age of 31 years old) as first dose, single for covid-19 immunisation. The patient''s medical history and concomitant medications were not reported. Patient has not had symptoms associated with COVID-19 and not had a COVID-19 test. Patient is not enrolled in clinical trial. The patient experienced chest pain on 04Jun2021 with outcome of recovering. The patient further described not unbearable but some sharp chest pain feels like from muscle or bones. Get worse when bending. Patient has not tested positive for COVID-19 since having the vaccine. No follow-up attempts are possible. No further information is expected.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166